Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTaylor Wimpey Regulatory News (TW.)

Share Price Information for Taylor Wimpey (TW.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 149.60
Bid: 149.55
Ask: 149.65
Change: 0.95 (0.64%)
Spread: 0.10 (0.067%)
Open: 150.40
High: 150.65
Low: 148.85
Prev. Close: 148.65
TW. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 - Remuneration update

1 Apr 2020 07:00

RNS Number : 3133I
Taylor Wimpey PLC
01 April 2020
 

 

1 April 2020

Taylor Wimpey plc

 

Further update in response to COVID-19 - Application of Remuneration Policy in 2020

On 24 March 2020, Taylor Wimpey plc (the 'Company') announced a number of measures that were taken in response to the COVID-19 pandemic in the interest of the safety and wellbeing of our colleagues and customers. This included the temporary closure of all show homes, sales centres and construction sites.

In recognition of the impact of these measures on the Company's stakeholders and at the request of the Executive Directors, the Company's Remuneration Committee (the 'Committee') has carefully considered the proposed application of the Remuneration Policy in 2020.

The Committee has taken the decision to use its available discretion to amend the application of the Remuneration Policy for 2020 and we announce the following changes to the Executive Directors' remuneration for this year:

- The 2% annual salary increase due to come into effect on 1 April 2020 has been cancelled;

- The Executive Incentive Scheme (annual bonus) has been cancelled and there will be no cash bonus payable in respect of the Company's performance in 2020; and

- A voluntary 30% reduction in base salary and pension for the duration of the Government-imposed lockdown. In the event that the lockdown continues beyond 30 June 2020, the Remuneration Committee will review this particular matter again at that time.

The decision to take a reduction in base salary is supported by the whole Board and therefore the Non-Executive Directors will also take a 30% reduction in their fees for the same period of time. The objective of these changes is to conserve cash, with a particular focus on protecting the long term financial security of the business as a whole, for the benefit of all of the Company's stakeholders.

The Committee is not proposing any amendments to the Remuneration Policy which has been submitted to shareholders for approval at the Company's Annual General Meeting on 23 April 2020.

There will be full disclosure of the above measures in the 2020 Directors' Remuneration Report.

 

-Ends-

 

For further information please contact:

Taylor Wimpey plc Tel: +44 (0) 1494 885616

Alice Marsden, Group Company Secretary

Debbie Archibald, Investor Relations

 

Finsbury Tel: +44 (0) 20 7251 3801

Faeth Birch

Anjali Unnikrishnan

 

Notes to editors:

 

Taylor Wimpey plc is a customer-focused residential developer, operating at a local level from 24 regional businesses across the UK. We also have operations in Spain.

 

For further information, please visit the Group's website:

www.taylorwimpey.co.uk

 

Follow us on Twitter via @TaylorWimpeyplc

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDFZGFFNMGGGZM
Date   Source Headline
7th Aug 20134:52 pmRNSDirector/PDMR Shareholding
1st Aug 201310:58 amRNSDirector/PDMR Shareholding
1st Aug 201310:53 amRNSTotal Voting Rights
31st Jul 20137:00 amRNSHalf year results
22nd Jul 20134:59 pmRNSHolding(s) in Company
16th Jul 20138:08 amRNSHolding(s) in Company
10th Jul 201310:29 amRNSDirector/PDMR Shareholding
4th Jul 20137:00 amRNSTrading update for the period ended 30 June 2013
1st Jul 201311:47 amRNSBlocklisting Interim Review
1st Jul 201311:44 amRNSBlocklisting Interim Review
1st Jul 201311:43 amRNSBlocklisting Interim Review
1st Jul 201311:40 amRNSBlocklisting Interim Review
1st Jul 201311:39 amRNSBlocklisting Interim Review
1st Jul 201311:33 amRNSBlocklisting Interim Review
1st Jul 201310:30 amRNSDirector/PDMR Shareholding
1st Jul 201310:26 amRNSTotal Voting Rights
26th Jun 20132:35 pmRNSHolding(s) in Company
19th Jun 20134:47 pmRNSHolding(s) in Company
11th Jun 20132:54 pmRNSDirector/PDMR Shareholding
3rd Jun 20132:44 pmRNSDirector Declaration
3rd Jun 20139:40 amRNSDirector/PDMR Shareholding
3rd Jun 20139:37 amRNSTotal Voting Rights
29th May 201312:16 pmRNSDirector/PDMR Shareholding
21st May 20134:58 pmRNSDirector/PDMR Shareholding
10th May 201312:44 pmRNSReplacement Notice of Results
9th May 20133:06 pmRNSDirector/PDMR Shareholding
8th May 20134:43 pmRNSReplacement Notice of Results
7th May 20139:33 amRNSNotice of Results
2nd May 201310:02 amRNSHolding(s) in Company
1st May 20139:57 amRNSDirector/PDMR Shareholding
1st May 20139:53 amRNSTotal Voting Rights
25th Apr 20132:38 pmRNSResult of AGM
25th Apr 20137:00 amRNSInterim Management Statement
23rd Apr 20132:57 pmRNSHolding(s) in Company
10th Apr 20135:56 pmRNSDirector/PDMR Shareholding
9th Apr 20134:57 pmRNSDirector/PDMR Shareholding
2nd Apr 20139:19 amRNSDirector/PDMR Shareholding
2nd Apr 20139:14 amRNSTotal Voting Rights
28th Mar 20133:41 pmRNSHolding(s) in Company
25th Mar 201311:29 amRNSDirector/PDMR Shareholding
12th Mar 20132:50 pmRNSHolding(s) in Company
12th Mar 201312:27 pmRNSDirector/PDMR Shareholding
12th Mar 20139:00 amRNSNotice of Results
6th Mar 20134:11 pmRNSDirector/PDMR Shareholding
1st Mar 20134:28 pmRNSHolding(s) in Company
1st Mar 20137:01 amRNSBoard Changes
1st Mar 20137:00 amRNSResults for the year ended 31 December 2012
12th Feb 20134:07 pmRNSHolding(s) in Company
12th Feb 20139:23 amRNSDirector/PDMR Shareholding
4th Feb 20133:58 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.